ArticleVeterinary and comparative oncology2022

Developing a translational murine-to-canine pathway for an IL-2/agonist anti-CD40 antibody cancer immunotherapy.

Stephen Francis Proksch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.